Apposite Capital said June 12 that its most recent healthcare fund, and associated vehicles, raised 144.5 million pounds ($193.4 million). Apposite Healthcare Fund II attracted support from existing investors and a group of new investors comprising fund of funds, financial institutions, family offices, endowments, foundations and corporates from Europe, Asia and the US. Apposite Capital, of London, focuses on healthcare and invests in the lower end of the middle market. Separately, Apposite said Valerie Auffray and Anne-Laure Meynier were promoted to head of investor relations & operations and investment director, respectively.
London, UK – 12 June 2018. Apposite Capital, the private equity firm with an exclusive focus on healthcare, today announces that it has successfully raised £144.5m of capital for Apposite Healthcare Fund II and associated vehicles (the “Fund”).
Apposite received strong support from existing investors and a well-diversified group of new investors comprising fund of funds, financial institutions, family offices, endowments, foundations and corporates from Europe, Asia and the US.
Apposite Capital is dedicated solely to healthcare investment and operates at the small end of the private equity market. It has been successful in building market leaders since 2006 providing both capital and expertise to healthcare businesses in the UK and Europe. Typically, Apposite seeks to deploy £10-20 million over the life of an investment with a preference for taking majority shareholdings. As a result of a strong pipeline, the Fund has already made five investments: Medical Imaging Partnership, MC Care Holdings, NIMGenetics, Swanton Care & Community and OrthoD Group.
Commenting on the fundraising, David Porter, Managing Partner, Apposite Capital said: “We are grateful for the support received from existing and new investors. It reflects the quality of our team and track record as well as investors’ growing appetite for specialist sector focused managers. We look forward to further deploying the Fund and to providing growth and small buyout capital to healthcare businesses in the UK and Europe with high growth potential.”
Valerie Auffray and Anne-Laure Meynier have also been promoted to Head of Investor Relations & Operations and Investment Director, respectively.
Valerie Auffray joined Apposite Capital in 2008. She is responsible for fundraising, investor relations, funds reporting, marketing, as well as the firm’s operations.
Anne-Laure Meynier joined the firm in 2015 and is involved in all aspects of the investment process from originating to executing and managing investments. She serves as a director of NIMGenetics and is an observer on the Swanton Care & Community board.
The fundraising was led by the Apposite Capital in-house team, with TMR Strategic LLP as lead placement agent. Macfarlanes acted as legal advisor and Intertrust as Fund administrator.